GSK plc
Utebzi
complicated urinary tract infections (cUTIs)
Resolved
20days ago
Approval decision · Jun 17, 2026
What's at stake
A final FDA approval decision on Utebzi for complicated urinary tract infections (cUTIs) is expected Jun 17, 2026.
Primary source
· SEC 6-K
verified 12h ago
“Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)”